Farrands P A, Perkins A, Sully L, Hopkins J S, Pimm M V, Baldwin R W, Hardcastle J D
J Bone Joint Surg Br. 1983 Nov;65(5):638-40. doi: 10.1302/0301-620X.65B5.6358231.
Immunoscintigraphy using radioisotope-labelled monoclonal antibody prepared against osteosarcoma 791T cells was used to detect a primary osteosarcoma. The eight-centimetre tumour was detected using rectilinear scintigraphy of 131I-labelled antibodies. Image enhancement was achieved by subtraction of blood-pool radioactivity labelled with technetium-99m. The ratio of tumour to non-tumour uptake of radioactivity (5:1) suggested that antibody targeting of therapeutic agents is feasible.